UAE Immunofluorescence Assay Market Size & Outlook

The immunofluorescence assay market in the UAE is expected to reach a projected revenue of US$ 28.0 million by 2030. A compound annual growth rate of 9.1% is expected of the UAE immunofluorescence assay market from 2024 to 2030.
Revenue, 2023 (US$M)
$15.3
Forecast, 2030 (US$M)
$28.0
CAGR, 2024 - 2030
9%
Report Coverage
UAE

UAE immunofluorescence assay market, 2018-2030 (US$M)

UAE

UAE immunofluorescence assay market highlights

  • The UAE immunofluorescence assay market generated a revenue of USD 15.3 million in 2023 and is expected to reach USD 28.0 million by 2030.
  • The UAE market is expected to grow at a CAGR of 9.1% from 2024 to 2030.
  • In terms of segment, indirect immunofluorescence was the largest revenue generating type in 2023.
  • Indirect Immunofluorescence is the most lucrative type segment registering the fastest growth during the forecast period.


Immunofluorescence assay market data book summary

Market revenue in 2023USD 15.3 million
Market revenue in 2030USD 28.0 million
Growth rate9.1% (CAGR from 2023 to 2030)
Largest segmentIndirect immunofluorescence
Fastest growing segmentIndirect Immunofluorescence
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIndirect Immunofluorescence, Direct Immunofluorescence
Key market players worldwideThermo Fisher Scientific Inc, Inova Diagnostics, Bio-Rad Laboratories Inc, Abcam PLC, PerkinElmer, Merck KGaA, Cell Signaling Technology, Sino Biological, Danaher Corp


Other key industry trends

  • In terms of revenue, UAE accounted for 0.4% of the global immunofluorescence assay market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia immunofluorescence assay market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 28.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Immunofluorescence Assay Market Companies

Name Profile # Employees HQ Website

UAE immunofluorescence assay market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunofluorescence assay market will help companies and investors design strategic landscapes.


Indirect immunofluorescence was the largest segment with a revenue share of 63.4% in 2023. Horizon Databook has segmented the UAE immunofluorescence assay market based on indirect immunofluorescence, direct immunofluorescence covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to UAE immunofluorescence assay market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE immunofluorescence assay market databook

  • Our clientele includes a mix of immunofluorescence assay market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE immunofluorescence assay market, including forecasts for subscribers. This country databook contains high-level insights into UAE immunofluorescence assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE immunofluorescence assay market report size, by type, 2018-2030 (US$M)

UAE Immunofluorescence Assay Market Share, 2023 & 2030 (US$M)

UAE immunofluorescence assay market report size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more